Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease

European Respiratory Journal

Volumn 22, Issue 2, 2003, Pages 280-285

  Gosker, H R ^a   Kubat, B ^a   Schaart, G ^a   van der Vusse, G J ^b   Wouters, E F M ^a   Schols, A M W J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Chronic obstructive pulmonary; Disease; Histological techniques; Skeletal muscle

Indexed keywords

CASPASE 3; PREDNISOLONE;

ADULT; AGE DISTRIBUTION; AGED; APOPTOSIS; ARTICLE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CELL COUNT; CELL DEATH; CELL NUCLEUS; CELL REGENERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FEMALE; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LEAN BODY WEIGHT; LEUKOCYTE; LUNG FIBROSIS; LUNG FUNCTION TEST; MACROPHAGE; MALE; MORPHOLOGY; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE FUNCTION; MUSCLE WEAKNESS; MYOPATHY; NICK END LABELING; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL ANALYSIS; VASTUS LATERALIS MUSCLE;

ADULT; AGED; APOPTOSIS; CASE-CONTROL STUDIES; FEMALE; FIBROSIS; HUMANS; MALE; MIDDLE AGED; MUSCLE CELLS; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 0041525699     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.03.00012803     Document Type: Article

References (26)

1. Bernard S, LeBlanc P, Whittom F, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 629-634.
2. Engelen MP, Schols AM, Does JD, Wouters EF. Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 2000; 71: 733-738.
3. Schols AM, Mostert R, Soeters PB, Wouters EF. Body composition and exercise performance in patients with chronic obstructive pulmonary disease. Thorax 1991; 46: 695-699.
4. Wood PH. Appreciating the consequences of disease: the international classification of impairments, disabilities, and handicaps. WHO Chron 1980; 34: 376-380.
5. Gosker HR, Wouters EF, van der Vusse GJ, Schols AM. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr 2000; 71: 1033-1047.
6. Pearson AM, Young RB. Diseases and disorders of muscle. Adv Food Nutr Res 1993; 37: 339-423.
7. Dubowitz V. Muscle Biopsy. A Practical Approach. London, Baillière Tindall, 1985.
8. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225-244.
9. Quanjer P, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Standardized lung function testing. Eur Respir J 1993; 6: 5-40.
10. Engelen MPKJ, Schols AMWJ, Heidendal GAK, Wouters EFM. Dual-energy X-ray absorptiometry in the clinical evaluation of body composition and bone mineral density in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 1998; 68: 1298-1303.
11. VanItallie TB, Yang MU, Heymsfield SB, Funk RC, Boileau RA. Height-normalized indices of the body's fat-free mass and fat mass: potentially useful indicators of nutritional status. Am J Clin Nutr 1990; 52: 953-959.
12. Bergstrom L. Muscle electrolytes in man. Determination by neutron activation analysis on needle biopsy specimens. A study on normal subjects, kidney patients, and patients with chronic diarrhoea. Scand J Clin Lab Invest 1962; 68: 1-110.
13. Gosker HR, van Mameren H, van Dijk PJ, et al. Skeletal muscle fibre type shifting and metabolic profile in patients with COPD. Eur Respir J 2002; 19: 617-626.
14. Gosker HR, Engelen MPKJ, van Mameren H, et al. Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr 2002; 76: 113-119.
15. Altman DG, Gore SM, Gardner MJ, Pocock SJ. Statistical guidelines for contributors to medical journals. Br Med J (Clin Res Ed) 1983; 286: 1489-1493.
16. O'Rourke KS. Myopathies in the elderly. Rheum Dis Clin North Am 2000; 26: 647-672.
17. Stoebner P, Mezin P, Vila A, Grosse R, Kopp N, Paramelle B. Microangiopathy of endoneurial vessels in hypoxemic chronic obstructive pulmonary disease (COPD). A quantitative ultrastructural study. Acta Neuropathol (Berl) 1989; 78: 388-395.
18. Ozge A, Atis S, Sevim S. Subclinical peripheral neuropathy associated pulmonary disease. Electromyogr Clin Neurophysiol 2001; 41: 185-191.
19. Decramer M, de Bock V, Dom R. Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153: 1958-1964.
20. McConkey DJ. Biochemical determinants of apoptosis and necrosis. Toxicol Lett 1998; 99: 157-168.
21. de Boer RA, van Veldhuisen DJ, van der Wijk J, et al. Additional use of immunostaining for active caspase 3 and cleaved actin and PARP fragments to detect apoptosis in patients with chronic heart failure. J Card Fail 2000; 6: 330-337.
22. Allen DL, Roy RR, Edgerton VR. Myonuclear domains in muscle adaptation and disease. Muscle Nerve 1999; 22: 1350-1360.
23. Vescovo G, Volterrani M, Zennaro R, et al. Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes. Heart 2000; 84: 431-437.
24. Eid AA, Ionescu AA, Nixon LS, et al. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 1414-1418.
25. Di Francia M, Barbier D, Mege JL, Orehek J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 150: 1453-1455.
26. Schols AM, Buurman WA, Staal van den Brekel AJ, Dentener MA, Wouters EF. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients pulmonary disease. Thorax 1996; 51: 819-824.